We are live on
!
Find out more
OPCM
Osborne Partners Capital Management Portfolio holdings
AUM
$1.89B
1-Year Est. Return
16.21%
This Fund
S&P 500
This Quarter
Est. Return
+1.65%
1 Year Est. Return
+16.21%
3 Year Est. Return
+47.57%
5 Year Est. Return
+57.2%
10 Year Est. Return
+245.88%
AUM
$703M
AUM Growth
+$4.58M
(+0.66%)
Cap. Flow
-$5.75M
Cap. Flow
% of AUM
-0.82%
Top 10 Holdings %
Top 10 Hldgs %
26.67%
Holding
184
New
7
Increased
75
Reduced
45
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$3.13M |
| 2 |
SHPG
Shire pic
SHPG
|
+$3.08M |
| 3 |
Synchrony
SYF
|
+$2.57M |
| 4 |
Broadcom
AVGO
|
+$2.1M |
| 5 |
DNOW Inc
DNOW
|
+$742K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$5.93M |
| 2 |
Bunge Global
BG
|
+$4.27M |
| 3 |
PayPal
PYPL
|
+$3.79M |
| 4 |
Artisan Partners
APAM
|
+$3.35M |
| 5 |
Centene
CNC
|
+$2.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.33% |
| 2 | Technology | 14.48% |
| 3 | Financials | 11.49% |
| 4 | Consumer Staples | 8.7% |
| 5 | Industrials | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $31.3M | 4.45% |
129,266
+577
| +0.4% | +$138K |
|
2
Microsoft
MSFT
$2.84T
| $24.1M | 3.43% |
349,440
+891
| +0.3% | +$61.2K |
|
3
JPMorgan Chase
JPM
$939B
| $21.1M | 3% |
230,579
+3,321
| +1% | +$287K |
|
4
Wells Fargo
WFC
$261B
| $19.6M | 2.79% |
353,693
+3,832
| +1% | +$205K |
|
5
Apple
AAPL
$4.89T
| $18.2M | 2.58% |
504,392
-66,432
| -12% | -$2.46M |
|
6
Invesco FTSE RAFI US 1000 ETF
PRF
$9.73B
| $16.6M | 2.36% |
802,245
+5,115
| +0.6% | +$105K |
|
7
Danaher
DHR
$135B
| $15.6M | 2.21% |
208,012
+1,615
| +0.8% | +$121K |
|
8
Procter & Gamble
PG
$343B
| $14.2M | 2.01% |
162,417
-295
| -0.2% | -$26K |
|
9
GE Aerospace
GE
$367B
| $13.7M | 1.95% |
105,868
+488
| +0.5% | +$66.9K |
|
10
ExxonMobil
XOM
$651B
| $13.3M | 1.89% |
164,759
-150
| -0.1% | -$12.3K |
|
11
SLB Ltd
SLB
$77.8B
| $13M | 1.85% |
197,171
+6,672
| +4% | +$478K |
|
12
Automatic Data Processing
ADP
$100B
| $11.9M | 1.69% |
116,266
-294
| -0.3% | -$29.8K |
|
13
Union Pacific
UNP
$183B
| $11.1M | 1.57% |
101,502
+653
| +0.6% | +$71.2K |
|
14
PepsiCo
PEP
$186B
| $11M | 1.56% |
95,185
+1,239
| +1% | +$142K |
|
15
Thermo Fisher Scientific
TMO
$211B
| $10.8M | 1.54% |
61,966
+1,299
| +2% | +$218K |
|
16
Pfizer
PFE
$140B
| $10.3M | 1.46% |
322,386
+805
| +0.3% | +$25.4K |
|
17
Walt Disney
DIS
$165B
| $10.2M | 1.45% |
96,207
+666
| +0.7% | +$72.9K |
|
18
CVS Health
CVS
$137B
| $9.67M | 1.38% |
120,143
+1,351
| +1% | +$107K |
|
|
19
LyondellBasell Industries
LYB
$19.5B
| $9.3M | 1.32% |
110,219
+37,723
| +52% | +$3.13M |
|
20
Abbott
ABT
$180B
| $9.15M | 1.3% |
188,273
+1,264
| +0.7% | +$57.2K |
|
21
Ecolab
ECL
$75.6B
| $8.87M | 1.26% |
66,826
+471
| +0.7% | +$60.9K |
|
22
Lowe's Companies
LOW
$116B
| $8.85M | 1.26% |
114,132
+2,126
| +2% | +$174K |
|
23
Invesco Dorsey Wright Momentum ETF
PDP
$1.5B
| $8.68M | 1.23% |
185,321
-3,909
| -2% | -$180K |
|
24
Alphabet (Google) Class C
GOOG
$3.9T
| $8.62M | 1.23% |
189,680
+2,900
| +2% | +$133K |
|
|
25
Synchrony
SYF
$23.7B
| $8.19M | 1.17% |
274,704
+86,743
| +46% | +$2.57M |
|
Similar funds
SIC
EP
DCP
VC
TF
SGF
TWA
LCP
Osborne Partners Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Osborne Partners Capital Management held 184 positions worth $703M, up 0.66% from $698M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Osborne Partners Capital Management's Q2 2017 filing shows 7 new, 75 increased, 45 reduced and 3 closed positions. Its largest new stake was Broadcom: 90,320 shares worth $2.1M. The largest sale was Novartis, an estimated $5.93M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Technology and Financials.
- Osborne Partners Capital Management's largest Q2 2017 buy was Broadcom: 90,320 shares worth $2.1M.
- Osborne Partners Capital Management added most to LyondellBasell Industries in Q2 2017, an estimated $3.13M increase.
- Osborne Partners Capital Management's biggest Q2 2017 reduction was Novartis, cutting an estimated $5.93M.
- Osborne Partners Capital Management fully exited Artisan Partners in Q2 2017, selling an estimated $3.35M.
- Osborne Partners Capital Management's ten largest holdings make up 27% of its $703M portfolio in Q2 2017.
- Osborne Partners Capital Management opened 7 new positions and closed 3 in Q2 2017.
- Osborne Partners Capital Management's portfolio value rose 0.66% quarter-over-quarter to $703M.
Based on Osborne Partners Capital Management's 13F filing for Q2 2017, filed 24 Jul 2017.